|
Biological Activity:
Potent and selective dopamine (DA) D2-receptor agonist; [11C]5-OH-DPAT is being developed as a PET agent for the high-affinity state of D2/3 receptors.
References:online 1, 2, 3, 4, 5
A Karlsson et al. (R)- and (S)-5-hydroxy-2-(dipropylamino)tetralin (5-OH DPAT): Assessment of optical purities and dopaminergic activities. Chirality. 1989-1995, 2(2), 90-95.
AK Nugroho et al. Transdermal iontophoresis of the dopamine agonist 5-OH-DPAT in human skin in vitro. J. Controlled Release 2005, 103(2), 393-403.
B Shi et al. Radiosynthesis and in vitro evaluation of 2-(N-alkyl-N-1'-11C-propyl)amino-5-hydroxytetralin analogs as high affinity agonists for dopamine D-2 receptors.Nucl Med Biol. 1999, 26(7), 725-35. (PubMed)
J Mukherjee et al. In vitro and in vivo evaluation of the binding of the dopamine D2 receptor agonist (11)C-(R,S)-5-hydroxy-2-(di-n-propylamino)tetralin in rodents and nonhuman primate.Synapse. 2000, 37(1), 64-70. (PubMed)
Chemical Name: 6-Dipropylamino-5,6,7,8-tetrahydro-naphthalen-1-ol hydrobromide
|